|
| 37507248 | Multi-institutional Development and External Validation of a Machine Learning Model for the Prediction of Distant Metastasis in Patients Treated by Salvage Radiotherapy for Biochemical Failure After Radical Prostatectomy. | Eur Urol Focus | 2024 |
| 37755384 | Impact of lymphadenectomy extent on immunotherapy efficacy in postresectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort study. | Int J Surg | 2024 |
| 37517600 | Assessing the Feasibility of Using Artificial Intelligence-Segmented Dominant Intraprostatic Lesion for Focal Intraprostatic Boost With External Beam Radiation Therapy. | Int J Radiat Oncol Biol Phys | 2024 |
| 34091506 | The Impact of Adjuvant Hemithoracic Radiation on Outcomes in Patients With Stage I-III Malignant Pleural Mesothelioma: A Dual Registry Analysis. | Ann Surg | 2023 |
| 37910103 | Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels: A Meta-Analysis. | JAMA Netw Open | 2023 |
| 37856213 | Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2023 |
| 37801315 | Risk of Short-Term Prostate-Specific Antigen Recurrence and Failure in Patients With Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial. | JAMA Netw Open | 2023 |
| 37485697 | Acute toxicity comparison of magnetic resonance-guided adaptive versus fiducial or computed tomography-guided non-adaptive prostate stereotactic body radiotherapy: AÂ systematic review and meta-analysis. | Cancer | 2023 |
| 37930194 | Burden of prostate cancer in the Middle East: A comparative analysis based on global cancer observatory data. | Cancer Med | 2023 |
| 37924333 | MR-guided prostate SBRT in prostate cancer patients with low-volume metastatic disease. | World J Urol | 2023 |
| 35690134 | China's Opaque Wall of Secrecy. | Ann Thorac Surg | 2023 |
| 37015332 | Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2023 |
| 37306641 | The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer. | J Thorac Cardiovasc Surg | 2023 |
| 37267581 | Reply to Z. Mai et al. | J Clin Oncol | 2023 |
| 36857638 | Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death. | J Clin Oncol | 2023 |
| 36872319 | The imperative for clinical trial diversity: Perspectives in the context of prostate-specific membrane antigen-targeted imaging. | Prostate Cancer Prostatic Dis | 2023 |
| 36609004 | Re: Population-based Randomized Trial of Screening for Clinically Significant Prostate Cancer ProScreen: A Pilot Study. | Eur Urol | 2023 |
| 36774208 | The Video-Assisted Thoracoscopic or Open Lobectomy (VIOLET) trial: The final chapter to this epic. | J Thorac Cardiovasc Surg | 2023 |
| 36868922 | Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer. | Eur Urol Oncol | 2023 |
| 36939057 | Cribriform morphology is associated with higher risk of biochemical recurrence after radical prostatectomy in patients with Grade Group 5 prostate cancer. | Histopathology | 2023 |
| 35872035 | Multi-institutional Care in Clinical Stage II and III Esophageal Cancer. | Ann Thorac Surg | 2023 |
| 36040026 | The Effect of Center Esophagectomy Volume on Outcomes in Clinical Stage I to III Esophageal Cancer. | Ann Surg | 2023 |
| 36376119 | Japanese Oncology Group 0802: Another giant leap. | J Thorac Cardiovasc Surg | 2023 |
| 33914478 | Utilization Trends and Volume-outcomes Relationship of Endoscopic Resection for Early Stage Esophageal Cancer. | Ann Surg | 2023 |
| 32209899 | The Impact of Adjuvant Therapy on Survival After Esophagectomy for Node-negative Esophageal Adenocarcinoma. | Ann Surg | 2022 |
| 35847547 | Magnetic Resonance-Guided Prostate Stereotactic Body Radiation Therapy With Daily Online Plan Adaptation: Results of a Prospective Phase 1 Trial and Supplemental Cohort. | Adv Radiat Oncol | 2022 |
| 35652585 | Second malignancy probabilities in patients with prostate cancer treated with whole pelvis radiation therapy versus prostate only radiation therapy. | Prostate | 2022 |
| 35616266 | Race-specific prostate cancer outcomes in a cohort of low and favorable-intermediate risk patients who underwent external beam radiation therapy from 1990 to 2017. | Cancer Med | 2022 |
| 35545176 | Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2022 |
| 35403057 | The 12 steps to a thoracoscopic anterior segment segmentectomy: Oncologically safe and sound. | JTCVS Tech | 2022 |
| 35373816 | A Delphi Consensus report from the "Prolonged Air Leak: A Survey" study group on prevention and management of postoperative air leaks after minimally invasive anatomical resections. | Eur J Cardiothorac Surg | 2022 |
| 35638719 | Race-specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990-2017. | Cancer Med | 2022 |
| 35465985 | Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysis. | Eur Urol | 2022 |
| 35715273 | Reply from authors: The boat, the sword, and the opacity of Chinese transplant data. | J Thorac Cardiovasc Surg | 2022 |
| 36509074 | NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023. | J Natl Compr Canc Netw | 2022 |
| 36562007 | Atrioesophageal Fistula After Atrial Fibrillation Ablation: A Case Report. | CJC Open | 2022 |
| 36249064 | Risk-adaptive paradigm for focal versus whole-gland salvage treatment for radio-recurrent prostate cancer. | Front Oncol | 2022 |
| 33857493 | Impact of Time to Endoscopic Resection on Outcomes for Stage I Esophageal Adenocarcinoma. | Ann Thorac Surg | 2022 |
| 35290082 | Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death. | J Clin Oncol | 2022 |
| 35130500 | Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2022 |
| 35154830 | MRI-Based Radiotherapy Planning to Reduce Rectal Dose in Excess of Tolerance. | Prostate Cancer | 2022 |
| 34596079 | Radical Minimally Invasive Surgery After Immuno-chemotherapy in Initially-unresectable Stage IIIB Non-small cell Lung Cancer. | Ann Surg | 2022 |
| 34711459 | Radiation Dose to the Intraprostatic Urethra Correlates Strongly With Urinary Toxicity After Prostate Stereotactic Body Radiation Therapy: A Combined Analysis of 23 Prospective Clinical Trials. | Int J Radiat Oncol Biol Phys | 2022 |
| 34329603 | The Impact of Extended Delayed Surgery for Indolent Lung Cancer or Part-Solid Ground Glass Nodules. | Ann Thorac Surg | 2022 |
| 33985811 | Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non-small cell lung cancer. | J Thorac Cardiovasc Surg | 2022 |
| 34315661 | The risk of death from prostate cancer in men with Gleason score 3+4 prostate cancer treated using brachytherapy with or without a short course of androgen deprivation therapy. | Urol Oncol | 2022 |
| 34314692 | Perioperative Outcomes and Survival After Preoperative Immunotherapy for Non-Small Cell Lung Cancer. | Ann Thorac Surg | 2022 |
| 33417330 | Tumor Size, Histology, and Survival After Stereotactic Ablative Radiotherapy and Sublobar Resection in Node-negative Non-small Cell Lung Cancer. | Ann Surg | 2022 |
| 32649467 | The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma. | Ann Surg | 2022 |
| 30946089 | A National Analysis of Short-term Outcomes and Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Clinical Stage II Non-Small-Cell Lung Cancer. | Ann Surg | 2021 |